Alerta

CUSTOMIZABLE PATIENT MONITORING DEVICE AND SYSTEM

Resumen de: WO2026177966A1

Patient monitoring devices, systems and methods are provided. A customizable patient monitoring device may include multiple ports allowing connection and disconnection of any of various physiological sensors. Signals from physiological sensors may be processed to obtain clinically presentable physiological information, which may include accessing the information from the signals or computing the information based at least in part on the signals. An arrangement of display units may be displayed on a monitoring device display of the customizable patient monitoring device, such as a grid of tiles, in which each tile may display information associated with a specific physiological parameter associated with a specific connected physiological sensor. A tile may be actuated by touch to display an enhanced display on the monitoring device display displaying additional information associated with the specific physiological parameter. The enhanced display may be actuated by touch to provide further information associated with the specific physiological parameter.

PERSONALIZED DIGITAL THERAPEUTICS FOR SKILLS TRAINING USING ROLE-BASED INTERACTIONS

Resumen de: US20260253748A1

Various examples, systems, and methods are disclosed relating to a roleplay pipeline for treatment and skill development. One or more processors can receive, for a roleplay interaction having a defined role for a user and a defined role for a chatbot, content in the roleplay interaction. The one or more processors further can apply the content as input to at least one artificial intelligence (AI) model to cause the at least one AI model to generate an output for the chatbot. The one or more processors further can provide, via a chatbot interface, the output. The digital therapeutic application can improve treatment by providing structured roleplay interactions that support social engagement, strengthen emotion regulation, and improve skill development and can increase the efficacy of the medication that the user is taking to address social skills, emotion skills, behavior challenges, and/or cognitive processing deficits.

VISION-BASED DETECTION OF ACCESS SHEATH

Resumen de: WO2026176271A1

This disclosure provides methods, devices, and systems for controlling robotically assisted medical systems. The present implementations more specifically relate to techniques for vision-based detection of an access sheath. In some aspects, a controller for a medical system obtains a series of images captured by a camera disposed on a distal tip of a medical instrument that is at least partially inserted through an access sheath. The controller infers a respective segmentation mask from each image in the series based on a machine learning model trained to classify each pixel of the image as depicting the access sheath or not depicting the access sheath, where the segmentation mask indicates how many pixels of the image are classified as depicting the access sheath. The controller further determines a position of the distal tip of the instrument relative to the access sheath based on the segmentation masks for the series of images.

WEARABLE ELECTRONIC DEVICE AND METHOD FOR DETECTING FINGER SIZE CHANGE USING SAME

Resumen de: WO2026177387A1

According to an embodiment of the present disclosure, a wearable electronic device may comprise: a housing having a ring shape; a plurality of pressure sensors spaced apart from each other in an inner space of the housing; at least one processor including processing circuitry; and a memory for storing instructions. According to an embodiment, the instructions, when executed individually or collectively by the at least one processor, may cause the wearable electronic device to obtain a plurality of pressure values through the plurality of pressure sensors. According to an embodiment, the instructions, when executed individually or collectively by the at least one processor, may cause the wearable electronic device to compare the plurality of obtained pressure values. According to an embodiment, the instructions, when executed individually or collectively by the at least one processor, may cause the wearable electronic device to determine, on the basis of a result of the comparison, that pressure has been generated according to the size of the finger of a user wearing the wearable electronic device, if the difference between the plurality of pressure values is within a designated range. In addition to various embodiments disclosed in the present document, other various embodiments are possible.

SYSTEMS AND METHODS FOR PROFILING COGNITIVE ABILITIES

Resumen de: US20260253505A1

0000 A system and method for measuring and assessing cognitive abilities of a user are disclosed. The method includes generating an individualized assessment protocol comprising a plurality of tasks each configured to evaluate cognitive mental specification. The method also includes the user selecting at least one task tasks using a semi-random process. The method further includes displaying a task-specific interface to present the selected task to user. The method includes receiving user responses to the task along with associated parameters. The method includes transmitting an individualized performance score table to a server. The method also includes processing the individualized performance scores using a population database, a neural network classifier, and regression models, which adjust their parameters based on the received scores. The method further includes computing individualized assessment scores to generate a profile of cognitive mental abilities. The method also includes transmitting profile of cognitive mental abilities to user device.

PREDICTING A TREATABLE HUNTINGTON'S DISEASE PATIENT/PATIENT POPULATION AND EFFECTS ON DISEASE PROGRESSION FOR THERAPIES TARGETING SOMATIC INSTABILITY

Resumen de: WO2026178535A1

Somatic instability (SI) in the mutant HTT allele is a high value therapeutic target for Huntington's Disease (HD). However, rates of SI and the speed of HD progression vary widely with inherited germline CAG repeat lengths across the HD patient population. Understanding this variability and projecting the treatable range of patients for SI-directed therapies is important to their design, preclinical development, and conferring optimal benefit to HD patients. A computational model and related method(s) track the percentage of healthy medium spiny neurons (MSNs) across the lifetime of HD patients. Changes in MSN survival are predicted based on an exemplary SI-directed interventional gene therapy. The range of treatable patients is also projected. The flexible framework provided by the computational model and related method(s) enables therapeutic performance prediction and projecting outcomes across the HD patient population and furthermore, serves as a valuable tool for defining the target populations for SI-directed therapies.

BONE ANCHORING DEVICE

Resumen de: US20260248538A1

A bone anchoring device for coupling a rod to bone includes an anchoring element with a shank and a head, a receiving part having a central axis, a channel for receiving the rod, and an accommodation space for accommodating the head of the anchoring element, and a pressure element positionable at least partially in the accommodation space to exert pressure on the head. The pressure element is configured to extend to an axial position that is lower than an axial position of a portion of the head having a greatest diameter.The head is pivotable relative to the receiving part, and has a first cooperating surface spaced apart axially from a free end of the head that is engageable with a second cooperating surface that is separable from the pressure element to limit pivoting of the head relative to the receiving part to a single plane.

HARDWARE-ACCELERATED NEUROMORPHIC SYSTEM FOR REAL-TIME OUTCOME MONITORING, MULTIMODAL ASSET GOVERNANCE, AND REGULATORY COMPLIANCE FOR TRANSPOSABLE SELF-RELIANT ENTITIES

Resumen de: US20260254923A1

A hardware-accelerated neuromorphic system and method are provided for real-time outcome monitoring of transposable transformations within an enterprise environment. The system utilizes a Neuromorphic System-on-Wafer (SoW) architecture comprising a plurality of Synaptic Processing Units (SPU) and AI accelerators to facilitate low-latency processing of neural correlates of consciousness (NCC). A shared synaptic chip interface identifies brain activity in a biological substrate and audits identified neural correlates against stored transformation blueprints and international regulatory standards, such as Wheaton System Engineering Standards, to validate desired transformational outcomes. The system further incorporates multimodal asset governance, where transformational outcomes may be collateralized by labor contracts or physical assets, ensuring identity continuity during distal reconstitution into mechatronic substrates.

INTELLIGENT DOSING PLATFORM WITH AGENTIC SOCIAL MEDIA INTEGRATION AND PATIENT SUPPORT NETWORK COORDINATION FOR INJECTABLE MEDICATION ADMINISTRATION

Resumen de: US20260249002A1

An intelligent dosing platform incorporating comprehensive social media integration and patient support network capabilities for injectable medication administration. The platform includes social media interface modules configured to facilitate medication-related communications across multiple social platforms, dosage detection modules that automatically trigger social media notifications and support group communications upon medication administration events, and patient network modules that connect patients with support groups and other patients with similar medication regimens. The system features agentic social network modules utilizing personal data assistants, personal LLM agents for automated content generation and scheduling management, and personal IoT network devices for enhanced social graph updates. Privacy management modules ensure HIPAA compliance while enabling user-controlled sharing of medication milestones and treatment achievements. Support group coordination modules facilitate virtual meetings and peer communications, while notification customization modules provide personalized updates for family members and caregivers based on detected medication administration events.

MICROENVIRONMENTAL MONITORING UTILIZING DIFFERENT TYPES OF SENSING DEVICES IN A BODY AREA NETWORK ASSOCIATED WITH A SUBJECT

Resumen de: US20260248389A1

0000 An apparatus comprises a processing device implementing a body area network (BAN) controller for a BAN associated with a subject. The processing device is configured to pair first and second sets of sensing devices with the BAN associated with the subject, the first set of sensing devices configured for physiologic monitoring of the subject and the second set of sensing devices configured for contextual monitoring of an environment of the subject. The processing device is also configured to enable data sharing of physiologic monitoring data obtained from the first set of sensing devices and contextual monitoring data obtained from the second set of sensing devices utilizing the BAN associated with the subject, and to determine, based on the physiologic monitoring data obtained from the first set of sensing devices and the contextual monitoring data obtained from the second set of sseennssiinngg devices, microenvironmental monitoring parameters associated with the subject.

ORAL PRODUCTS, THREE-DIMENSIONAL PRINTERS USED FOR FORMING ORAL PRODUCTS, AND THREE-DIMENSIONAL PRINTING METHODS FOR FORMING ORAL PRODUCTS

Resumen de: WO2025111344A1

A method of making an oral product includes printing a first product portion of an oral product using of a three-dimensional printer. The first product portion has a first composition. The method further includes printing a second product portion of the oral product using the three-dimensional printer, the second product portion having a second composition different from the first composition, the first product portion and the second product portion defining distinct, non-mixed regions of the oral product.

DEVICES AND RELATED METHODS FOR VENTILATION

Resumen de: EP4796155A2

Provided herein are devices and methods that relate to ventilation and respiration. In one embodiment, a ventilator device comprising a fluidic amplifier with one or more coaxially aligned components, where there are no internal moving components. In another embodiment, a device and related methods for treating a patient who needs ventilation such as after infection by the coronavirus Covid-19.

NEBULISER

Resumen de: EP4796149A1

0001 The present invention provides a nebuliser (100) comprising one or more inputs (110), and a plurality of droplet ejectors (126) in fluid communication with the one or more inputs (110). Each droplet ejector comprises a nozzle portion and a piezoelectric actuator. The one or more inputs are for receiving one or more liquids. Each nozzle portion defines a nozzle outlet in fluid communication with the one or more inputs. Each piezoelectric actuator is operable to cause ejection of a liquid received by one of the one or more inputs through the respective nozzle outlet as one or more droplets. The nebuliser is configured to generate an aerosol comprising the respective one or more droplets ejected by one or more of the plurality of droplet ejectors. At least 50%, by mass, of the droplets of the aerosol have a diameter of at least 5 x 10<-6> m.

SYSTEMS, DEVICES, COMPONENTS AND METHODS FOR DETECTING THE LOCATIONS OF SOURCES OF CARDIAC RHYTHM DISORDERS IN A PATIENT'S HEART

Resumen de: EP4797280A2

0001 Disclosed are various examples and embodiments of systems, devices, components and methods configured to detect a location of a source of at least one cardiac rhythm disorder in a patient's heart. In some embodiments, electrogram signals are acquired from a patient's body surface, and subsequently normalized, adjusted and/or filtered, followed by generating a two-dimensional spatial map, grid or representation of the electrode positions, processing the amplitude-adjusted and filtered electrogram signals to generate a plurality of three-dimensional electrogram surfaces corresponding at least partially to the 2D map, one surface being generated for each or selected discrete times, and processing the plurality of three-dimensional electrogram surfaces through time to generate a velocity vector map corresponding at least partially to the 2D map. The resulting velocity vector map maybe employed to classify a patient as one of an A-type patient, a B-type patient, and a C-type patient, and to guide therapy subsequently delivered to the patient. Trained atrial discriminative machine learning models that facilitate the foregoing systems and methods, and that provide predictions or results concerning a patient's condition, are also disclosed.

MEDICATION DELIVERY SYSTEM

Resumen de: EP4797275A1

A medication delivery system, including a wearable device configured to automatically deliver medication based on food order information received from a user computing device. The medication is delivered via a pump, and the medication may be insulin. The food order information includes timing information and/or information about the food ordered necessary to change a medication delivery. A controller determines a medication adjustment based on an estimated physiological response to the food order information. A delivery pump automatically delivers the medication, e.g., an insulin bolus, prior to or in anticipation of food consumption.

METHOD FOR PRODUCING PATIENT-OPTIMISED DOSAGE FORMS

Resumen de: ZA202307295B

The present application relates to methods of personalised pharmaceutics. More specifically, the invention relates to methods for the production of pharmaceutical dosage forms, which are produced by 3D and/or 2D printing, whereby a wide variety of parameters relevant to the administration of the dosage form can be changed depending on the analysis of patient- and disease-specific data and can be adapted in the course of the patient's treatment. In this way, the quality of treatment for the patient can be improved in the future and significantly increased from the point of view of patient safety.

RESIN COMPOSITION FOR STEREOLITHOGRAPHY

Resumen de: EP4796568A1

0001 The present invention provides a resin composition for stereolithography that exhibits excellent strength, toughness, water resistance, and stress retention in the shaped article while reducing the amount of leachables. The present invention relates to a resin composition for stereolithography comprising a monofunctional methacrylic polymerizable compound having a plurality of independent aromatic rings (A), a polyfunctional (meth)acrylic polymerizable compound (B), and a photopolymerization initiator (C).

A METHOD FOR VOLUMETRIC PRINTING A DENTAL COMPONENT BY PHOTOPOLYMERIZATION OF A PHOTOCURABLE RESIN

Resumen de: EP4796291A1

0001 A method for volumetric printing a dental component by photopolymerization of a photocurable resin.

POLYOXAZOLIDONE DERIVATIVES AND THEIR USE IN MEDICAL DEVICES

Resumen de: EP4541837A1

The invention provides poly(hydroxy oxazolidone) compounds (PHOx) corresponding to following formula (I) or formula (II):whereinR_1', R_2', independently of one another each denote a C1 to C20 alkyl group, preferably a C1 to C10 alkyl group, more preferably a C1 to C3 alkyl group, most preferably a methyl group, and- R₃, R₄ independently of one another each denote hydrogen or a C1 to C20 alkyl group, preferably a C1 to C10 alkyl group, more preferably a C1 to C3 alkyl group, most preferably a methyl group, and- R₅, R_5', R₆, R_6', independently of one another each denote hydrogen or a C1 to C20 alkyl group, preferably a C1 to C10 alkyl group, more preferably a C1 to C3 alkyl group, most preferably a methyl group, or an aryl group, preferably a phenyl group, and- A is an organic linking group selected from a linear, branched, saturated, unsaturated, cyclic and/or non-cyclic aliphatic, aromatic or araliphatic hydrocarbon group, preferably having 1 to 20, more preferably 1 to 12, most preferably 1 to 8 carbon atoms and optionally further containing one or more functional groups selected from ether, ester, amide, amine, carboxyl, sulfur, halogen and/or urethane, and- Optionally A, R₃ and R₄ in formula (I) are linked to each other to form a cyclic structure, and- Optionally R₅ and R_5', and/or R₆ and R_6' in formula (II) are respective

A SHRINKING AND SETTING BIOINK

Resumen de: WO2025099720A1

Provided is a hybrid hydrogel composition and methods for its preparation and use in 3D printing biomaterials for tissue engineering applications. The hybrid hydrogel composition comprises discrete hydrogel particles of a first crosslinked polymeric network, interpenetrated- through and threaded by a second crosslinked polymeric network, dispersed in a medium. The first polymer is a thermo-responsive polymer, while the second is a protein-based thermo¬ denaturing polymer. The process for preparing this composition involves mixing swelled hydrogel nanoparticles of the first polymer with a non-crosslinked hydrogel of the second polymer in the presence of a crosslinking agent for the first polymer. The 3D printing method utilizes this composition below the LCST of the thermo-responsive polymer, followed by temperature increase wherein the second polymer cures and fixes the printed ink. This approach enables the creation of high-resolution structures, including artificial tissues with capillary blood vessels, featuring dimensions less than 50 μm.

Orthodontic device and method

Resumen de: GB2704295A

A dental appliance 20 for correcting jaw relationships, the dental appliance comprising a lower shell for fitting over the lower set of teeth, and an upper shell for fitting over the upper set of teeth. Each of the upper and lower shells comprise a mandibular alteration ridge 42, 44 configured to project occlusally on each side of the shell. Each mandibular alteration ridge comprises at least one guide surface 32, 36 and one or more buttresses 34, 38, wherein a guide surface of a mandibular alteration ridge of the upper shell is configured to engage a guide surface of a mandibular alteration ridge of the lower shell to displace the mandible relative to the maxilla as the jaw closes. A method of correcting a Class II or Class III malocclusion using such an appliance is also disclosed. Figure 2B

SYSTEM MAINTAINANCE TECHNIQUES

Resumen de: WO2025088603A1

A service providing apparatus is disclosed comprising a service platform configured for movement along a path having one or more object treatment zones, each object treatment zone comprising equipment configured to apply one or more treatment processes to surface areas of objects carried by one or more objects' platforms along said path. At least one service providing unit is mounted on the service support platform for applying one or more service procedures to the equipment of at least one of the one or more object treatment zones while the support platform is located within the at least one treatment zone, to thereby apply the one or more service procedures while the one or more objects' platforms are located along the path.

ELECTRONIC DEVICE, AND METHOD FOR OUTPUTTING NOTIFICATION SIGNAL FOR MEDICATION INTAKE BY USING SAME

Resumen de: EP4796098A1

According to an embodiment, the electronic device may comprise a display, a processor, and a memory for storing a medication intake schedule, and instructions. The instructions, when executed by the processor, may cause the electronic device to: display a clock screen including an icon for at least one medication on the basis of the medication intake schedule; identify a notification time for the intake of the at least one medication on the basis of the medication intake schedule; identify an adjustment condition for a medication intake-related notification signal on the basis of the identified notification time; adjust an output time point of the notification signal for the intake of the at least one medication, on the basis of the identified adjustment condition of the medication intake-related notification signal; and display a visual effect corresponding to the icon included in the clock screen, on the basis of the adjusted output time point. Various other embodiments may be possible.

A DEVICE AND METHOD FOR ANALYZING EMOTIONS AND HUMAN RELATIONSHIPS USING COLORS AND A COMPUTER PROGRAM THEREFOR

Resumen de: US20260245265A1

Disclosed is a device and method for analyzing an emotion and a human relationship based on a color. The device includes a display; and a processor electrically connected to the display, wherein the processor is configured to: display an application for analyzing an emotion and a human relationship based on a color on the display; identify a color corresponding to a user, a color corresponding to an age group of the user, a color corresponding to each of emotions of the user, and a color corresponding to an acquaintance of the user as input from the user through the displayed application; extract RGB values of each of the identified colors, convert the extracted RGB values into three-dimensional color coordinates, and display the converted three-dimensional color coordinates on the application.

運動障害のための遠隔リハビリテーション治療のシステムおよび方法

Nº publicación: JP2026528725A 25/08/2026

Solicitante:

エンコラ、インコーポレイテッド

Resumen de: WO2025029698A1

A system for remote rehabilitation of a movement disorder of a patient is presented. A system includes a wearable device. A wearable device includes a sensor configured to generate movement data of a patient. Movement data is indicative of one or more movement disorder symptoms of a patient. A wearable device includes a processor in communication with a sensor. A wearable device includes a stimulator in communication with a processor. A processor is configured to cause a stimulator to stimulate a body part of a patient based on movement data. A wearable device includes a wireless communication unit in communication with a processor. A system includes a virtual platform running on a server in communication with a wearable device via a wireless communication unit. A virtual platform is programmed to receive movement data from a wearable device.